首页> 外文期刊>Drug Design, Development and Therapy >Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction
【24h】

Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction

机译:eon药苷改善急性心肌梗死大鼠模型的心功能并减少不良的梗死后左心室重构

获取原文
       

摘要

Background: Paeoniflorin (PF) is the active component of Paeonia lactiflora Pall. or Paeonia veitchii Lynch. This study was, therefore, aimed to evaluate the improvement and mechanism of the PF on ventricular remodeling in rats with acute myocardial infarction (AMI). Materials and methods: In this study, AMI model was established by ligating the anterior descending coronary artery in Wistar rats. After 4 weeks gavage of PF, the apparent signs and the left ventricle weight index of Wistar rats were observed. The left ventricular ejection fraction (LVEF) was evaluated by Doppler ultrasonography. Changes in cardiac morphology were observed by pathologic examination, and apoptosis was observed by the terminal deoxynucleotidyl transferase dUTP nick end labeling assay. In addition, enzyme-linked immunosorbent assay was used to detect the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) interleukin-10 (IL-10) and brain natriuretic peptide (BNP). Immunohistochemistry and Western blot method were applied to detect Caspase-3 and Caspase-9. Results: Compared with the model control, the survival conditions of rats in all treatment groups were generally improved after PF treatment. LVEF was significantly increased, and both left ventricular end-diastolic inner diameter and left ventricular end-systolic inner diameter were significantly reduced. Moreover, pathologic examination showed that the myocardium degeneration of the rats treated with PF was decreased, including neater arrangement, more complete myofilament, more uniform gap and less interstitial collagen fibers. Furthermore, the mitochondrial structure of cardiomyocytes was significantly improved. The ultrastructure was clear, and the arrangement of myofilament was more regular. Also, the expression of Caspase-3 and Caspase-9 was inhibited, and apoptosis was obviously reduced in the PF treatment groups. BNP, TNF-α and IL-6 were also decreased and IL-10 was increased in the treated rats. Conclusion: PF could significantly improve the LVEF of rats. It decreased adverse left ventricular remodeling after myocardial infarction in rat models. The potential mechanism could be that PF decreased and inhibited BNP, TNF-α and IL-6, increased IL-10 and further inhibited the expression of Caspase-3 and Caspase-9, thus promoting ventricular remodeling.
机译:背景:eon药(PF)是Pa药中的活性成分。或Pa药veitchii林奇。因此,本研究旨在评估PF对急性心肌梗死(AMI)大鼠心室重构的改善作用及其机制。材料与方法:本研究通过结扎Wistar大鼠冠状动脉前降支建立AMI模型。灌胃4周后,观察Wistar大鼠的体征和左心室重量指数。通过多普勒超声检查评估左心室射血分数(LVEF)。通过病理学检查观察心脏形态的变化,并且通过末端脱氧核苷酸转移酶dUTP缺口末端标记测定法观察到凋亡。此外,酶联免疫吸附法用于检测肿瘤坏死因子-α(TNF-α),白介素-6(IL-6),白介素-10(IL-10)和脑利钠肽(BNP)的表达。采用免疫组织化学和Western blot方法检测Caspase-3和Caspase-9。结果:与模型对照组相比,PF治疗后各治疗组大鼠的生存状况普遍改善。 LVEF显着增加,左心室舒张末期内径和左心室收缩末期内径均显着减小。此外,病理检查显示,用PF处理的大鼠的心肌变性降低,包括更整齐的排列,更细的肌丝,更均匀的间隙和更少的间质胶原纤维。此外,心肌细胞的线粒体结构得到了显着改善。超微结构清晰,肌丝排列更规则。另外,在PF处理组中,Caspase-3和Caspase-9的表达被抑制,凋亡明显减少。在治疗的大鼠中,BNP,TNF-α和IL-6也降低,IL-10升高。结论:PF可明显改善大鼠左室射血分数。它减少了大鼠心肌梗死后不良的左心室重塑。潜在的机制可能是PF降低并抑制BNP,TNF-α和IL-6,IL-10升高并进一步抑制Caspase-3和Caspase-9的表达,从而促进心室重构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号